Posted by Michael Wonder on 25 May 2023
Australians battling with prostate cancer to benefit from new PBS listing
25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine under the PBS.
From 1 June 2023, Australians with metastatic hormone sensitive prostate cancer will have access to apalutamide (Erlyand) through the PBS.
